Fraud Blocker
January 31, 2025
Author: Shelby
  • Home
  • /
  • Blog
  • /
  • Research in a Nutshell: Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer

This week, our research article is focusing on the potential risk of lymphedema after undergoing a sentinel lymph node biopsy (SLNB) in the axilla, or armpit, of the side affected by breast cancer.

 

The article nicely details how there is already a known difference between the risk of developing lymphedema after an axillary lymph node dissection (ALND). During this type of procedure, many, if not all, lymph nodes in the armpit are removed due to the concern for or actual presence of cancer that has spread to these lymph nodes. While ALND used to be the common go-to during surgery, as more patients were observed to develop post-operative lymphedema, many surgeons are now opting for an initial SLNB, if appropriate.

 

If the SLNB does not show concern for spread of the breast cancer to the axillary lymph nodes, then a dissection can be avoided. If there is concern for spread of the cancer, then an ALND may still be necessary. It has been found though, that the SLNB has been able to reduce the occurrence of lymphedema onset in patients with breast cancer.

 

While the occurrence of lymphedema has been able to be reduced with a SLNB, the risk is not completely eliminated. This article aims to dive into how much of a risk there actually is in developing lymphedema after a SLNB.

 

Let’s dive into things a bit further!

 

Research Methods

The article describes how they refined their search to a database of women diagnosed with breast cancer, who underwent surgical removal at Seoul National University Hospital. Data was retrieved during the time frame of 1/1/2014-12/31/2020 only for those who underwent a SLNB. For the purposes of the study, this was called the development group.

 

The data pulled from the development group was used to find and acknowledge possible risk factors for lymphedema onset and create a prediction model. These models were then appropriately validated from information retrieved from surgical patients between January 2014-December 2016.

 

Information that was gathered included the following:

  • Age

  • BMI

  • Type of surgery performed

  • If chemotherapy was implemented before or after surgery

  • If radiation therapy was performed

  • Number of harvested lymph nodes (narrowed down to those with > 3 lymph nodes harvested)

 

The specific criteria for correctly identifying and diagnosing lymphedema was also established. The diagnostic criteria included the following:

  • A difference of > 200mL volume in comparison to the opposite arm

  • A 10% increase in limb volume

  • Or a difference of > 2.0cm circumference in the upper arm or forearm of the affected limb

 

The research primarily focused on those who used perometry for diagnosing lymphedema. This focuses on using an infrared light to scan and measure limb volume, in comparison to circumferential measurements using a tape measure; however, if patients were unable to assume the necessary positioning for the perometry measurements, then circumferential measurements using a tape measure were used instead.

 

Specific software and models were used to break down the collected data and create the final predictive model and criteria for risk of developing lymphedema after a SLNB. Four groups, with varying levels of risk, were created:

  • Low

  • Intermediate-low

  • Intermediate-high

  • High

 

The final model was then further analyzed using specifical statistical date, which is specifically detailed in the research article.

 

Research Results

Results time!

 

Here’s what the research found:

  • In the development group, the low risk and intermediatelow risk groups had < 1.0% risk of developing lymphedema; whereas, the high risk group had a > 3.3% chance of developing lymphedema.

 

  • In the validation group, the low risk and intermediatelow risk groups also had a < 1.0% risk of developing lymphedema; whereas, the high risk group had a > 1.7% chance of developing lymphedema.

 

The overall incidence of lymphedema onset in the data analyzed was 0.9%.

 

The following factors were the largest contributors for onset of lymphedema:

  • Both neoadjuvant and adjuvant chemotherapy

  • Radiation therapy

  • BMI > 30 kg/m2

  • If > 3 lymph nodes were harvested during the biopsy

 

Out of the above factors, chemotherapy and the number of lymph nodes harvested (>3) were found to be the most important and determining factors for risk of lymphedema developing.

 

Take-Home Message

All in all, a SLNB creates a much lower risk for development of lymphedema versus an ALND.

 

When the choice and necessity of a SLNB is made by you and your surgical team, factors to consider for potential lymphedema risk include if you are also receiving or will need chemotherapy, radiation therapy, if you have a higher BMI, and if > 3 lymph nodes will be removed (which often may not be able to be determined until the surgeon is performing the surgery).

 

It’s always important to be open with your medical team regarding any concerns you have about developing lymphedema.

 

It can be beneficial, if you know you have even a small risk for lymphedema onset, to request a referral to a Certified Lymphedema Therapist (CLT). They will be able to teach you preventative strategies, look for signs and symptoms consistent with lymphedema, as well as address any active swelling if it presents.

Resource

1.   Jinyoung Byeon, Kang E, Jung JJ, et al. Risk of Lymphedema After Sentinel Node Biopsy in Patients With Breast Cancer. Journal of Breast Cancer. 2024;27(5):323-323. doi:https://doi.org/10.4048/jbc.2024.0180.

Shoulder Rehab Tools

We Know Shoulders.

Reduce or eliminate your shoulder pain in as little as 3 days...even if you've tried everything else and failed!


Whether you are pre- or post-op, the proven "shoulder pulley" method is the most affordable thing you can try to fix your shoulder. 

About the Author Shelby

Shelby Green is a Florida-licensed Doctor of Physical Therapy (DPT), currently practicing at St. Anthony’s Resource Center Outpatient Rehabilitation in St. Petersburg, FL. Shelby received her Bachelor of Science in Biology from the University of South Florida, followed by her DPT from the University of St. Augustine for Health Sciences. Shelby has 6 years clinical experience practicing in both the acute care and outpatient rehab settings. Specialties include orthopedics, with additional training in specific manual therapy techniques for pain management, as well as extensive training as a Certified Lymphedema Therapist.

Shelby is a Tampa, FL native, which is where she and her husband currently reside. Their favorite activities include spending time with family and anything outdoors, such as walking, bike riding, and going to the beach.

Medical Disclaimer

This website is intended to provide educational information only and should not be taken as medical advice. The information shared on this website is based on research, but is not intended to replace the advice of a healthcare professional. We recommend that you consult your healthcare provider for any specific questions or concerns you may have. The website does not accept responsibility for any harm that may occur from using the information given on this site. Speak to your medical provider about any health issues!

Have comments? Fire away...

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}
Processing...